Clemens Krepler

Clemens Krepler

UNVERIFIED PROFILE

Are you Clemens Krepler?   Register this Author

Register author
Clemens Krepler

Clemens Krepler

Publications by authors named "Clemens Krepler"

Are you Clemens Krepler?   Register this Author

52Publications

1717Reads

49Profile Views

Acetylsalicylic Acid Governs the Effect of Sorafenib in -Mutant Cancers.

Clin Cancer Res 2018 03 1;24(5):1090-1102. Epub 2017 Dec 1.

Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844814PMC
March 2018

Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in -Mutant Ovarian Cancer Models.

Clin Cancer Res 2017 06 19;23(12):3097-3108. Epub 2016 Dec 19.

Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474193PMC
June 2017

MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition.

Eur J Cancer 2017 03 3;73:93-101. Epub 2017 Feb 3.

Center for Dermatooncology, Department of Dermatology, Liebermeisterstr. 25, University Hospital Tübingen, 72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.012DOI Listing
March 2017

The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition.

Eur J Cancer 2017 03 3;73:85-92. Epub 2017 Feb 3.

Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Liebermeisterstr. 25, 72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.010DOI Listing
March 2017

Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma.

Mol Cancer Res 2016 09 13;14(9):767-75. Epub 2016 Jun 13.

Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-16-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025362PMC
September 2016

An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.

Cancer Cell 2016 09 11;30(3):485-498. Epub 2016 Aug 11.

Department of Oncological Sciences, Department of Dermatology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.06.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021590PMC
September 2016

Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.

PLoS One 2014 29;9(1):e84417. Epub 2014 Jan 29.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria ; Division of Hematology & Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0084417PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906015PMC
September 2014

Highlights of melanoma research presented at the 49th annual meeting of the American Society of Clinical Oncology in Chicago, 2013.

Pigment Cell Melanoma Res 2014 Jan 1;27(1):E1-5. Epub 2013 Nov 1.

Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12182DOI Listing
January 2014

Neoplastic stem cells: current concepts and clinical perspectives.

Crit Rev Oncol Hematol 2010 Nov 25;76(2):79-98. Epub 2010 Feb 25.

Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2010.01.001DOI Listing
November 2010

Loss of novel mda-7 splice variant (mda-7s) expression is associated with metastatic melanoma.

J Invest Dermatol 2004 Sep;123(3):583-8

Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, Vienna General Hospital, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0022-202X.2004.23321.xDOI Listing
September 2004

CpG oligonucleotides elicit antitumor responses in a human melanoma NOD/SCID xenotransplantation model.

J Invest Dermatol 2004 Feb;122(2):387-91

Department of Dermatology, Division of General Dermatology, University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.0022-202X.2004.22202.xDOI Listing
February 2004

Antitumor effect of G3139 Bcl-2 antisense oligonucleotide is independent of its immune stimulation by CpG motifs in SCID mice.

Antisense Nucleic Acid Drug Dev 2002 Dec;12(6):359-67

Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/108729002321082438DOI Listing
December 2002